Product Liability

MORRISTOWN, NJ – Consumers are advised that on January 31, 2025, Alvogen, Inc., voluntarily recalled a single lot of its Fentanyl Transdermal System 25 mcg/h transdermal patches because a defect was identified in the product’s delivery system. Fentanyl Transdermal System 25 mcg/h transdermal patches are indicated to help opioid-tolerant patients

BOWDOIN, ME – In an update released on November 29, 2024, the FDA has now identified an FHC Inc. recall as Class I, the most serious type, over concerns that a manufacturing size error could result in patient harm. Initiated on October 3, 2024, the recall covers Lot Number 244517

ROCHESTER, MI – As many as 16 lots of Clonazepam Orally Disintegrating Tablets, USP (C-IV) have been added to a voluntary recall by Endo USA, Inc., because the product cartons may be labeled with the incorrect strength, according to the FDA. Indicated to be taken alone or “as an adjunct

When do you have a case, and what kinds of cases are there? By Super Lawyers staff | Reviewed by Canaan Suitt, J.D. | Last updated on July 13, 2023 Featuring practical insights from contributing attorney Jami S. Oliver Read the Article